Cocrystal Pharma, Inc. (COCP)
Last updated: 2026-10-24 03:52:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Cocrystal Pharma, Inc. (COCP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.95, with a market capitalization of $18.18M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.76 to $2.03. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$18.18M | |
$0.92 | |
$77.40 | |
$0.76 | |
$0.91 | |
43.44K | |
58.75K | |
-- | |
$2.03 | |
$0.76 | |
-- | |
-- |
Cocrystal Pharma, Inc. (COCP) Latest Closing Stock Price
Cocrystal Pharma, Inc. (COCP) last closed at $0.91 as of 2026-10-23 20:42:00, unchanged from the previous close of $0.91.
During the latest regular trading session, COCP traded between $0.76 and $77.40, with a volume of 43.44K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Cocrystal Pharma, Inc. (COCP) 7-Day Stock Price Change
Over the past seven days, Cocrystal Pharma, Inc. (COCP) moved from $1.04 to $0.95, representing a decline of 8.75% ($0.09).
The stock traded between $0.88 and $1.18 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 44.10 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
COCP 52-Week Price Position
Position in Range: 14.9%
COCP is currently trading at $0.95, placing it 14.9% of the way from its 52-week low of $0.76 to its 52-week high of $2.03. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Cocrystal Pharma, Inc. (COCP)?
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
Cocrystal Pharma, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 10 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Cocrystal Pharma, Inc. (COCP) Stock on MEXC
Eligible investors can buy real shares of Cocrystal Pharma, Inc. (COCP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Cocrystal Pharma, Inc. (COCP) stock price today?
2.Is COCP stock going up or down today?
3.What is COCP pre-market price?
4.What is COCP after-hours price?
5.Is COCP stock trading now?
6.Where does COCP sit relative to its 52-week high and low?
7.What sector is Cocrystal Pharma, Inc. in?
8.What is Cocrystal Pharma, Inc.'s market capitalization and where is it listed?
9.How is COCP valued in terms of P/E ratio and EPS?
10.Does Cocrystal Pharma, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
COCP Stock Calculator
Estimate the value between COCP shares and USD.
COCP Shares to USD
1.00 COCP shares = 0.949 USD
Calculations are estimates based on the latest available price and are for reference only.


